INTEST CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 11/17/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $113.8M | $130.7M | — | $123.3M | $116.8M |
| Cost of revenue | $64.9M | $75.3M | — | $66.3M | $63.4M |
| Gross profit | $48.9M | $55.4M | — | $57.0M | $53.4M |
| Research and development | $9.4M | $8.5M | — | $7.6M | $7.5M |
| Operating expenses | $52.6M | $52.0M | — | $46.5M | $42.7M |
| Operating income | -$3.7M | $3.4M | — | $10.4M | $10.7M |
| Interest expense | $450,000 | $846,000 | — | $679,000 | $635,000 |
| Pretax income | -$3.2M | $3.5M | — | $11.0M | $10.1M |
| Income tax expense | -$695,000 | $563,000 | — | $1.7M | $1.7M |
| Net income | -$2.5M | $2.9M | — | $9.3M | $8.5M |
| Balance Sheet | |||||
| Cash and equivalents | $14.2M | $19.8M | — | $45.3M | $13.4M |
| Current assets | $78.6M | $78.8M | — | $85.8M | $60.1M |
| Total assets | $151.3M | $152.3M | — | $134.8M | $110.1M |
| Current liabilities | $35.8M | $31.9M | — | $24.3M | $26.9M |
| Total liabilities | $47.7M | $52.5M | — | $38.5M | $45.1M |
| Stockholders' equity | $103.6M | $99.8M | — | $96.3M | $65.0M |
| Cash Flow Statement | |||||
| Cash from operations | $7.3M | $3.8M | — | $16.2M | -$1.4M |
| Depreciation and amortization | $6.8M | $5.4M | — | $4.7M | $4.7M |
| Stock-based compensation | $1.6M | $1.9M | — | $2.0M | $1.8M |
| Capital expenditure | $1.6M | $1.3M | — | $1.3M | $1.4M |
| Free cash flow | $5.7M | $2.5M | — | $14.9M | -$2.8M |
| Share repurchases | $0 | $1.0M | $1.0M | $0 | — |
Shares outstanding 12.6M · Free float 78.2%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.